The mechanistic basis of IGF2BP2's role in PCa involves METTL3-mediated m6A modification of Prostate Cancer Associated Transcript 6 (PCAT6), leading to the upregulation of PCAT6 in an IGF2BP2-dependent manner [134]. Here, PCAT6 is linked to posterior cortical atrophy.